4.5 Article

Clinical, radiologic, and pathologic features and outcomes of pulmonary transthyretin amyloidosis

期刊

RESPIRATORY MEDICINE
卷 194, 期 -, 页码 -

出版社

W B SAUNDERS CO LTD
DOI: 10.1016/j.rmed.2022.106761

关键词

Pulmonary transthyretin amyloidosis; Cardiac transthyretin amyloidosis; Nodular parenchymal; Diffuse alveolar septal

向作者/读者索取更多资源

Pulmonary amyloidosis is a less common but clinically important manifestation of transthyretin amyloidosis (ATTR), characterized by deposition of misfolded transthyretin protein in the lung tissue. This study retrospectively reviewed the clinical course, imaging characteristics, pathology results, and outcomes of a patient cohort diagnosed with pulmonary ATTR. The findings highlight the importance of recognizing and understanding pulmonary involvement in ATTR.
Introduction: Amyloid transthyretin amyloidosis (ATTR) is characterized by deposition of a misfolded conformation of the transport protein TTR, most commonly in cardiac and nerve tissue, causing clinical disease. Pulmonary amyloidosis, or deposition of ATTR in lung tissue, is a poorly characterized manifestation of this disease. We present the clinical course, imaging characteristics, pathology results, and outcomes of a patient cohort diagnosed with pulmonary ATTR. Methods: We retrospectively reviewed records of 28 patients with pulmonary ATTR seen at Mayo Clinic from September 30, 2005, through December 31, 2020. Data collected included information on demographics, subjective symptoms, tissue biopsy results, pulmonary function testing, imaging findings, and treatment. Results: Of the patients, 89% were men; the median age was 74.5 years (range, 50-99 years). Patients were typically diagnosed after persistent dyspnea and abnormal chest imaging resulted in lung biopsy, which yielded the ATTR diagnosis. Most patients had a preexisting diagnosis of cardiac ATTR. The disease was wild-type in 62% and hereditary in 38%. Normal pulmonary function tests followed by a restrictive pattern were the most common presentation. Of the patients, 93% had chest computed tomography, with common findings of diffuse nodularity, calcified granulomas, interlobular septal thickening, and pleural effusions. Almost all patients had pulmonary vascular involvement, and half had interstitial involvement on tissue biopsy. One-third received either antiamyloid pharmacotherapy or a heart transplant. Half of patients had died before the time of study inclusion. Conclusion: Pulmonary disease is a less common but clinically important manifestation of ATTR.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据